Pinnacle Financial Partners (Tennessee)’s AbbVie ABBV Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$42M	Buy	181,236 +9,680	+6%	+$1.97M	1%	19
2025 Q2	$31.8M	Buy	171,556 +536	+0.3%	+$99.6K	0.67%	28
2025 Q1	$35.5M	Sell	171,020 -2,958	-2%	-$575K	0.72%	27
2024 Q4	$31.1M	Sell	173,978 -1,676	-1%	-$308K	0.63%	29
2024 Q3	$34.7M	Buy	175,654 +4,441	+3%	+$829K	0.7%	27
2024 Q2	$29.4M	Sell	171,213 -993	-0.6%	-$164K	0.63%	34
2024 Q1	$31.4M	Buy	172,206 +2,457	+1%	+$423K	0.68%	30
2023 Q4	$26.3M	Sell	169,749 -1,461	-0.9%	-$213K	0.62%	35
2023 Q3	$25.5M	Sell	171,210 -240	-0.1%	-$35.2K	0.66%	38
2023 Q2	$23.1M	Buy	171,450 +1,136	+0.7%	+$167K	0.58%	48
2023 Q1	$27.1M	Buy	170,314 +12,852	+8%	+$1.96M	0.73%	32
2022 Q4	$25.4M	Buy	157,462 +5,357	+4%	+$821K	0.73%	33
2022 Q3	$20.4M	Buy	152,105 +4,523	+3%	+$649K	0.74%	37
2022 Q2	$22.6M	Buy	147,582 +3,863	+3%	+$590K	0.81%	30
2022 Q1	$23.3M	Sell	143,719 -2,874	-2%	-$417K	0.74%	33
2021 Q4	$19.8M	Buy	146,593 +2,514	+2%	+$297K	0.62%	40
2021 Q3	$15.5M	Buy	144,079 +7,227	+5%	+$826K	0.55%	53
2021 Q2	$15.4M	Buy	136,852 +26,126	+24%	+$2.94M	0.62%	44
2021 Q1	$12M	Buy	110,726 +1,641	+2%	+$176K	0.54%	54
2020 Q4	$11.6M	Sell	109,085 -2,048	-2%	-$197K	0.57%	50
2020 Q3	$9.73M	Buy	111,133 +1,469	+1%	+$138K	0.53%	57
2020 Q2	$10.8M	Buy	109,664 +4,377	+4%	+$385K	0.61%	46
2020 Q1	$8.02M	Buy	105,287 +1,315	+1%	+$112K	0.55%	52
2019 Q4	$9.21M	Sell	103,972 -785	-0.7%	-$65.2K	0.57%	53
2019 Q3	$7.93M	Buy	104,757 +5,351	+5%	+$367K	0.57%	56
2019 Q2	$7.23M	Sell	99,406 -8,421	-8%	-$662K	0.54%	55
2019 Q1	$8.69M	Buy	107,827 +6,331	+6%	+$518K	0.7%	44
2018 Q4	$9.36M	Sell	101,496 -6,319	-6%	-$556K	0.89%	28
2018 Q3	$10.2M	Buy	107,815 +715	+0.7%	+$67.8K	0.86%	31
2018 Q2	$9.92M	Buy	107,100 +2,737	+3%	+$267K	0.94%	25
2018 Q1	$9.88M	Sell	104,363 -9,397	-8%	-$1.03M	1%	21
2017 Q4	$11M	Buy	113,760 +721	+0.6%	+$68K	1.16%	15
2017 Q3	$10M	Buy	113,039 +1,932	+2%	+$147K	1.29%	13
2017 Q2	$8.06M	Buy	111,107 +33,375	+43%	+$2.24M	1.14%	17
2017 Q1	$5.07M	Buy	77,732 +2,306	+3%	+$145K	1%	28
2016 Q4	$4.72M	Buy	75,426 +3,123	+4%	+$191K	1.02%	27
2016 Q3	$4.58M	Sell	72,303 -1,021	-1%	-$66.1K	1.03%	26
2016 Q2	$4.64M	Buy	73,324 +7,449	+11%	+$454K	1.07%	26
2016 Q1	$3.76M	Buy	65,875 +9,474	+17%	+$528K	0.97%	33
2015 Q4	$3.34M	Buy	56,401 +2,528	+5%	+$146K	1.04%	23
2015 Q3	$2.93M	Buy	53,873 +10,202	+23%	+$664K	0.92%	33
2015 Q2	$2.93M	Buy	43,671 +959	+2%	+$62.6K	0.93%	39
2015 Q1	$2.5M	Buy	42,712 +5,071	+13%	+$306K	0.84%	45
2014 Q4	$2.46M	Buy	37,641 +3,131	+9%	+$197K	0.86%	44
2014 Q3	$1.99M	Buy	34,510 +9,610	+39%	+$534K	0.76%	48
2014 Q2	$1.41M	Buy	24,900 +2,519	+11%	+$132K	0.56%	61
2014 Q1	$1.15M	Buy	22,381 +1,300	+6%	+$65.7K	0.51%	63
2013 Q4	$1.11M	Buy	21,081 +7,928	+60%	+$390K	0.51%	65
2013 Q3	$588K	Buy	13,153 +479	+4%	+$21.2K	0.29%	86
2013 Q2	$523K	Buy	+12,674	New	+$554K	0.27%	86

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s ABBV Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) increased its AbbVie (ABBV) stake by 5.6% in Q3 2025, buying an estimated $1.97M and bringing the position to 181,236 shares worth $42M. The position accounts for 1% of the portfolio, ranked #19.

Pinnacle Financial Partners (Tennessee) first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Pinnacle Financial Partners (Tennessee) held 181,236 shares of AbbVie worth $42M as of Q3 2025.
Pinnacle Financial Partners (Tennessee) bought 9,680 AbbVie shares in Q3 2025, an estimated $1.97M.
AbbVie made up 1% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #19 holding.
Pinnacle Financial Partners (Tennessee) first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.